Business Segments scPharmaceuticals Inc.
Stocks
SCPH
US8106481059
Pharmaceuticals
|
Market Closed -
Nasdaq
16:00:00 2025-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 5.670 USD | -.--% |
|
-.--% | - |
| 25-10-07 | MannKind Corporation completed the acquisition of scPharmaceuticals Inc.. | CI |
| 25-10-07 | MannKind Completes Acquisition of scPharmaceuticals | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | - | - | - | 13.59M | 36.33M | |||||
Total Assets | 109M | 79.04M | 124M | 94.48M | 108M | |||||
Interest Expense | -2.59M | -2.58M | -3.3M | -8.12M | -7.57M | |||||
CAPEX | - | -9K | -21K | -40K | -21K | |||||
EBT | -32.21M | -28.03M | -36.84M | -54.81M | -85.15M | |||||
D&A | 399K | 438K | 468K | 626K | 148K | |||||
Operating Income | -29.93M | -25.82M | -36.16M | -55.4M | -64.78M | |||||
Net Income | -32.21M | -28.03M | -36.84M | -54.81M | -85.15M |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | - | - | - | 13.59M | 36.33M | |||||
Total Assets | 109M | 79.04M | 124M | 94.48M | 108M | |||||
Interest Expense | -2.59M | -2.58M | -3.3M | -8.12M | -7.57M | |||||
D&A | 399K | 438K | 468K | 626K | 148K | |||||
CAPEX | - | -9K | -21K | -40K | -21K | |||||
Net Income | -32.21M | -28.03M | -36.84M | -54.81M | -85.15M | |||||
EBT | -32.21M | -28.03M | -36.84M | -54.81M | -85.15M | |||||
Operating Income | -29.93M | -25.82M | -36.16M | -55.4M | -64.78M |
- Stock Market
- Stocks
- SCPH Stock
- Financials scPharmaceuticals Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
